Jakob Ribbing

1.2k total citations · 1 hit paper
21 papers, 1.0k citations indexed

About

Jakob Ribbing is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Statistics and Probability. According to data from OpenAlex, Jakob Ribbing has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 5 papers in Statistics and Probability. Recurrent topics in Jakob Ribbing's work include Asthma and respiratory diseases (7 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Inhalation and Respiratory Drug Delivery (5 papers). Jakob Ribbing is often cited by papers focused on Asthma and respiratory diseases (7 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Inhalation and Respiratory Drug Delivery (5 papers). Jakob Ribbing collaborates with scholars based in Sweden, United States and United Kingdom. Jakob Ribbing's co-authors include E. Niclas Jonsson, Lars Lindbom, Joakim Nyberg, Ola Caster, Steven W. Martin, Mats O. Karlsson, Walter Reinisch, Bengt Hamrén, Maria Svensson and Fabio Cataldi and has published in prestigious journals such as European Respiratory Journal, Clinical Pharmacology & Therapeutics and Clinical Pharmacokinetics.

In The Last Decade

Jakob Ribbing

20 papers receiving 986 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Perl-speaks-NONMEM (PsN)—a Perl module for NONMEM related programming

2004 635 citations Lars Lindbom, Jakob Ribbing et al. Computer Methods and Programs in Biomedicine profile →

Peers

Jakob Ribbing

PHARM

ONCOL

PPCH

Nidal Al‐Huniti United States

DR Mould United States

MO Karlsson Sweden

Kaori Kadoyama Japan

Samer Mouksassi United States

Justin Wilkins United States

Elizabeth Ludwig United States

Philippe Jacqmin Belgium

Karl Brendel France

Eric Snoeck Belgium

Nidal Al‐Huniti United States

Jakob Ribbing

226 ×1.3

PHARM

280 ×1.7

ONCOL

103 ×0.7

166 ×1.2

PPCH

226 ×1.8

Citations per year, relative to Jakob Ribbing Jakob Ribbing (= 1×) peers Nidal Al‐Huniti

Countries citing papers authored by Jakob Ribbing

Since Specialization

Citations

This map shows the geographic impact of Jakob Ribbing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakob Ribbing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakob Ribbing more than expected).

Fields of papers citing papers by Jakob Ribbing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jakob Ribbing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakob Ribbing. The network helps show where Jakob Ribbing may publish in the future.

Co-authorship network of co-authors of Jakob Ribbing

This figure shows the co-authorship network connecting the top 25 collaborators of Jakob Ribbing. A scholar is included among the top collaborators of Jakob Ribbing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jakob Ribbing. Jakob Ribbing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hartmann, Sylvia, et al.. (2025). Exposure‐Efficacy Meta‐Model of Nintedanib in Adult Patients With Chronic Fibrosing Interstitial Lung Diseases. CPT Pharmacometrics & Systems Pharmacology. 15(1). e70132–e70132.

Sanghavi, Kinjal, Jakob Ribbing, James A. Rogers, et al.. (2024). Covariate modeling in pharmacometrics: General points for consideration. CPT Pharmacometrics & Systems Pharmacology. 13(5). 710–728. 22 indexed citations

Kassir, Nastya, Jurgen Langenhorst, Jakob Ribbing, et al.. (2022). Exposure‐response relationships of etrolizumab in patients with moderately‐to‐severely active ulcerative colitis. CPT Pharmacometrics & Systems Pharmacology. 11(9). 1234–1243. 5 indexed citations

Lu, Tong, Siv Jönsson, Jakob Ribbing, et al.. (2022). Population pharmacokinetic analysis of etrolizumab in patients with moderately‐to‐severely active ulcerative colitis. CPT Pharmacometrics & Systems Pharmacology. 11(9). 1244–1255. 5 indexed citations

Svensson, Robin J., Jakob Ribbing, Naoki Kotani, et al.. (2021). Population repeated time‐to‐event analysis of exacerbations in asthma patients: A novel approach for predicting asthma exacerbations based on biomarkers, spirometry, and diaries/questionnaires. CPT Pharmacometrics & Systems Pharmacology. 10(10). 1221–1235. 7 indexed citations

Kotani, Naoki, Michael Dolton, Robin J. Svensson, et al.. (2021). Population Pharmacokinetics and Exposure‐Response Relationships of Astegolimab in Patients With Severe Asthma. The Journal of Clinical Pharmacology. 62(7). 905–917. 3 indexed citations

Slejko, Julia F., Richard J. Willke, Jakob Ribbing, & Peter A. Milligan. (2016). Translating Pharmacometrics to a Pharmacoeconomic Model of COPD. Value in Health. 19(8). 1026–1032. 11 indexed citations

Ribbing, Jakob, et al.. (2015). Predicting Reductions in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations from FEV1-A Model-Based Meta-Analysis of Literature Data from Controlled Randomized Clinical Trials. Journal of Pharmacokinetics and Pharmacodynamics. 42. 2 indexed citations

Karlsson, MO, et al.. (2015). A model‐based longitudinal meta‐analysis of FEV₁ in randomized COPD trials. Clinical Pharmacology & Therapeutics. 99(3). 315–324. 9 indexed citations

10.

Fogel, Robert, Kathleen Shields, Jared Christensen, et al.. (2013). A phase II, randomised, placebo controlled trial of 12 weeks treatment with an oral p38 inhibitor in patients with COPD on a background of ICS/LABA. European Respiratory Journal. 42(Suppl 57). 186–186. 4 indexed citations

11.

Diderichsen, Paul M., Eugène Cox, Steven W. Martin, Adriaan Cleton, & Jakob Ribbing. (2013). Characterizing Systemic Exposure of Inhaled Drugs: Application to the Long-Acting β2-Agonist PF-00610355. Clinical Pharmacokinetics. 52(6). 443–452. 9 indexed citations

12.

Diderichsen, Paul M., Eugène Cox, Steven W. Martin, Adriaan Cleton, & Jakob Ribbing. (2013). Predicted heart rate effect of inhaledPF‐00610355, a long acting β‐adrenoceptor agonist, in volunteers and patients with chronic obstructive pulmonary disease. British Journal of Clinical Pharmacology. 76(5). 752–762. 5 indexed citations

13.

Wang, Xipei, Dewei Shang, Jakob Ribbing, et al.. (2012). Placebo effect model in asthma clinical studies: longitudinal meta-analysis of forced expiratory volume in 1 second. European Journal of Clinical Pharmacology. 68(8). 1157–1166. 14 indexed citations

14.

Nielsen, Jace, Matthew M. Hutmacher, Adriaan Cleton, Steven W. Martin, & Jakob Ribbing. (2012). Longitudinal FEV1 dose–response model for inhaled PF-00610355 and salmeterol in patients with chronic obstructive pulmonary disease. Journal of Pharmacokinetics and Pharmacodynamics. 39(6). 619–634. 10 indexed citations

15.

Ribbing, Jakob, Bengt Hamrén, Maria Svensson, & Mats O. Karlsson. (2010). A Model for Glucose, Insulin, and Beta‐Cell Dynamics in Subjects With Insulin Resistance and Patients With Type 2 Diabetes. The Journal of Clinical Pharmacology. 50(8). 861–872. 32 indexed citations

16.

Ribbing, Jakob, Andrew C. Hooker, & E. Niclas Jonsson. (2007). Non-Bayesian knowledge propagation using model-based analysis of data from multiple clinical studies. Journal of Pharmacokinetics and Pharmacodynamics. 35(1). 117–137. 1 indexed citations

17.

Ribbing, Jakob, Joakim Nyberg, Ola Caster, & E. Niclas Jonsson. (2007). The lasso—a novel method for predictive covariate model building in nonlinear mixed effects models. Journal of Pharmacokinetics and Pharmacodynamics. 34(4). 485–517. 61 indexed citations

18.

Ribbing, Jakob. (2007). Covariate Model Building in Nonlinear Mixed Effects Models. KTH Publication Database DiVA (KTH Royal Institute of Technology). 5 indexed citations

19.

Ribbing, Jakob & E. Niclas Jonsson. (2004). Power, Selection Bias and Predictive Performance of the Population Pharmacokinetic Covariate Model. Journal of Pharmacokinetics and Pharmacodynamics. 31(2). 109–134. 137 indexed citations

20.

Lindbom, Lars, Jakob Ribbing, & E. Niclas Jonsson. (2004). Perl-speaks-NONMEM (PsN)—a Perl module for NONMEM related programming. Computer Methods and Programs in Biomedicine. 75(2). 85–94. 635 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact